Sonio Suspect

FDA 510(k) K261519 · Sonio

Substantially Equivalent

510(k) numberK261519

Submission

Device name
Sonio Suspect
Applicant
Sonio
Paris, FR
Received
May 7, 2026
Decision date
June 4, 2026
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
POK – Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer
Device class
Class II (moderate risk)
Regulation
21 CFR 892.2060
Specialty
Radiology

Assist users in characterizing lesions identified on acquired medical images

Other 510(k)s with product code POK

510(k)DeviceApplicantDecision
K253884Koios DS (3.8)POK · Traditional Koios Medical, Inc.07/02/2026SE
K254161Automated Aortic Stenosis Software (AutoAS)POK · Traditional GE Medical Systems Ultrasound & Primary Care…03/27/2026SE
K251769RevealAI-LungPOK · Traditional Precision Medical Ventures, Inc. Dba Revealdx01/30/2026SE
K252294Fetal EchoScan (v1.2)POK · Traditional Brightheart12/08/2025SE
K250221StrokeSENS ASPECTS Software ApplicationPOK · Traditional Circle Cardiovascular Imaging, Inc.07/01/2025SE
K251071Fetal EchoScan (v1.1)POK · Special Brightheart05/02/2025SE
K243614Sonio SuspectPOK · Traditional Sonio02/21/2025SE
K243294Brainomix 360 e-ASPECTSPOK · Traditional Brainomix Limited02/14/2025SE
K242130Koios DSPOK · Traditional Koios Medical, Inc.11/15/2024SE
K242342Fetal EchoScanPOK · Traditional Brightheart11/14/2024SE

More from Brightheart

510(k)DeviceDecision
K252433Sonio Detect (v3)IYN · Traditional 03/16/2026SE
K243614Sonio SuspectPOK · Traditional 02/21/2025SE
K240406Sonio DetectIYN · Traditional 04/26/2024SE
K230365Sonio DetectIYN · Traditional 07/25/2023SE

Questions and answers

When was Sonio Suspect cleared by the FDA?

Sonio Suspect (K261519) received a 510(k) decision of Substantially Equivalent on June 4, 2026, 28 days after the submission was received.

What is the product code of K261519?

The FDA product code is POK – Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer, a Class II (moderate risk) device regulated under 21 CFR 892.2060.